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Abstract
Interleukin-1b (IL-1b) activates the production of reactive oxygen species (ROS) and secretion of MMPs as well as
chondrocyte apoptosis. Those events lead to matrix breakdown and are key features of osteoarthritis (OA). We confirmed
that in human C-20/A4 chondrocytes the NADPH oxidase Nox4 is the main source of ROS upon IL-1b stimulation. Since
heme molecules are essential for the NADPH oxidase maturation and activity, we therefore investigated the consequences
of the modulation of Heme oxygenase-1 (HO-1), the limiting enzyme in heme catabolism, on the IL-1b signaling pathway
and more specifically on Nox4 activity. Induction of HO-1 expression decreased dramatically Nox4 activity in C-20/A4 and
HEK293 T-RExTM Nox4 cell lines. Unexpectedly, this decrease was not accompanied by any change in the expression, the
subcellular localization or the maturation of Nox4. In fact, the inhibition of the heme synthesis by succinylacetone rather
than heme catabolism by HO-1, led to a confinement of the Nox4/p22phox heterodimer in the endoplasmic reticulum with
an absence of redox differential spectrum highlighting an incomplete maturation. Therefore, the downregulation of Nox4
activity by HO-1 induction appeared to be mediated by carbon monoxide (CO) generated from the heme degradation
process. Interestingly, either HO-1 or CO caused a significant decrease in the expression of MMP-1 and DNA fragmentation
of chondrocytes stimulated by IL-1b. These results all together suggest that a modulation of Nox4 activity via heme
oxygenase-1 may represent a promising therapeutic tool in osteoarthritis.
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Introduction
The pathogenesis of osteoarthritis involves an imbalance
between anabolic and catabolic pathways in chondrocytes. The
expression of matrix metalloproteinases (MMPs), chondrocyte
hypertrophy and apoptosis are the main features of the
pathology. Proinflammatory cytokines, such as interleukin-1b
(IL-1b) and tumor necrosis factor-a (TNF-a) cause damages to
cartilage via the synthesis and the secretion of MMPs, which in
turn lead to matrix degradation [1,2,3,4,5]. Indeed, elevated
levels of IL-1b were found in OA synovial fluid, and the
expression of IL-1b gene is up-regulated in OA cartilage [6]. In
response to IL-1b, articular chondrocytes actively produce
reactive oxygen species (ROS). ROS have been suggested to
act as secondary messengers in bovine chondrocytes and are
involved in AP-1 and NF-kappaB activation pathways leading to
the transcription of cytokine-induced MMP-1 and MMP-13
metalloproteinases [7,8,9,10]. The maturity-arrested differentia-
tion state, also called hypertrophic differentiation that could
promote OA progression, is observed among OA chondrocytes
in situ. Indeed, hypertrophic chondrocytes undergo apoptosis
leading to a dysregulation of matrix repair mechanism [11].
The role of ROS is nowadays well established in this terminal
differentiation [12,13,14].
ROS are important regulators of redox-sensitive cell-signalling
pathways and are involved in various biological processes
including host defence, cell signalling, oxygen sensing, cell
proliferation, differentiation and apoptosis. However, overproduc-
tion of ROS has been associated with many pathological
conditions such as inflammation, vascular atherosclerosis, diabetes,
hypertension, tumorigenesis, neurodegenerative pathologies and
osteoarthritis [15,16]. NADPH oxidases (Nox) function of is solely
dedicated to the production of ROS. Nox2 NADPH oxidase
activity in phagocyte is well characterized and plays an essential
role in innate immunity [17]. Nox family is composed of seven
members who share specific structural homology regions [18].
Among them, Nox4 represents the major source of ROS in kidney
and is widely expressed in many others tissues including the
vascular system and bones [19,20]. For example, in osteoclasts,
ROS production by Nox4 has been shown to directly contribute to
bone resorption [20].
Despite evidences of ROS implication in OA, only few studies
investigated the function of NADPH oxidase in human chondro-
cytes. Recently, Coustry and co-workers demonstrated that Nox4
PLOS ONE | www.plosone.org 1 June 2013 | Volume 8 | Issue 6 | e66478
mRNA is 100 fold upregulated in a chondrocyte model of
pseudoachondroplasia characterized by abnormal joint architec-
ture, joint erosion and osteoarthritis [21]. Our previous data
showed that the oxidase complex Nox4/p22phox is expressed in the
C-20/A4 human chondrocyte cell line and represents an
important source of ROS generation [22]. In this cell line, Nox4
activity modulates MMP-1 expression and DNA fragmentation
upon IL-1b treatment, events that are implicated in OA
pathogenesis. Consequently, targeting Nox4 activity may represent
a promising therapeutic strategy against osteoarthritis.
NADPH oxidase catalytic activity is dependent on two heme
molecules which transfer electrons from the FAD to molecular
oxygen to give rise to superoxide anion (O2u
2). Heme oxygenase-1
(HO-1) is the limiting enzyme in heme catabolism. HO-1 catalyzes
the linearization of the heme molecule to produce an equimolar
amount of biliverdine (BV) and carbon monoxide (CO). BV is
subsequently converted to bilirubin (BR) by the NADPH biliverdin
reductase. BV and BR are potent antioxidants [23] while CO has
strong anti-inflammatory properties [24]. During Nox2 matura-
tion, heme is incorporated into a 65 kDa precursor allowing its
dimerization with the stabilizing subunit p22phox [25]. The
complex called cytochrome b558 (cyt b558) is then glycosylated
and addressed to the plasma membrane. In presence of
succinylacetone, a heme synthesis inhibitor, the maturation
process was markedly reduced causing a significant decrease of
NADPH oxidase activity [26].
In this study, we investigate whether the modulation of HO-1
expression could inhibit Nox4 activity and consequently reduce
MMP-1 secretion and cell death. We first observed that the
inhibition of heme synthesis by succinylacetone affected profound-
ly Nox4/p22phox heterodimer formation and subcellular localiza-
tion emphasising the role of heme synthesis in the Nox4/p22phox
maturation. Conversely, heme catabolism by HO-1 decreased
Nox4 activity in the C-20/A4 chondrocytes and in the HEK293
T-RExTM Nox4 cells without affecting the Nox4/p22phox hetero-
dimer formation and plasma membrane addressing. In fact, our
results suggest that HO-1 inhibits Nox4 activity through carbon
monoxide generated through the heme degradation process.
Interestingly, in chondrocyte stimulated by IL-1b, inhibition of
Nox4 activity by HO-1 led to a significant decrease in the
expression of the MMP-1, DNA fragmentation and cell death.
This suggests that the cartilage homeostasis provided by chondro-
cytes could depend on the balance between Nox4 and HO-1
expression, and may qualify Nox4 and HO-1 as potential
therapeutic targets in osteoarthritis.
Materials and Methods
Material
Chemical reagents used in this study and their sources were the
following: Dulbecco’s modified Eagle’s medium (DMEM), fetal
bovine serum (FBS) and geneticin (G418) (life technologies, Saint
Aubin, France); blasticidin (Funakoshi Co, Tokyo, Japan); AMV
Reverse transcriptase (QBiogene, Illkirch, France); Zero Blunt
TOPO PCR cloning kit, TRIzolH reagent, Taq polymerase, Alexa
Fluor 488, 546 or 633 labelled goat anti-mouse IgG, Alexa Fluor
546 anti-rabbit, Alexa Fluor 546 anti-goat, Hoechst 33258, pEFb
and pcDNA3.1 plasmids (Invitrogen, Cergy Pontoise, France);
ECL Western Blotting detection reagents and Goat anti-Mouse
IgG-HRP antibody (GE healthcare, Buckingamshire, England);
Na4P2O7, Na3VO4, PMSF, luminol, Horseradish Peroxidase
(HRPO), Triton X-100, protoporphyrin-IX cobalt chloride
(CoPP-IX), succinylacetone (SA), tricarbonylchlororutenium (II)
dimer (CORM-II), ruthenium III chloride (RuCl) and bilirubin
(BR) (SIGMA, Saint Quentin Fallavier, France); Biliverdin
hydrochloride (BV) (tebu-bio, Le Perray en Yvelines, France);
Okadaic acid, leupeptin, pepstatin, trypsin inhibitor, TLCK,
human interleukin-1b, complete mini EDTA-free protease inhib-
itor EASYpack, FuGENE transfection reagent and lactate
dehydrogenase (LDH) optimized kits (Roche, Meylan, France);
diisopropylfluorophosphate (DFP, Acros Organics, Halluin,
France); polyclonal Ig from goat against HO-1 (sc-7695) or
against actin (sc-1615) and control Ig (Santa Cruz Biotechnologies,
Heidelberg, Germany); Lab-Tek chambered coverglass (Thermo
scientific, Courtaboeuf, France); anti-MMP-1 monoclonal anti-
body (mAb 901) (R&D Systems, Lille, France); Rabbit polyclonal
Ig against calnexin (ab10286) or against VDAC (ab28777)
(Abcam, Paris, France); mammalian expression plasmid encoding
for Nox4A or Nox4B (pEFb) [22]; pcDNA 3.1 Nox4GFP and
Nox4 monoclonal antibodies (8E9 and 6B11) [27].
Cell Lines and Culture
Human C-20/A4 chondrocyte cell line is a gift from Dr M.B.
Goldring (Harvard Institute of Medicine, Boston, MA, USA) [5].
HEK293 T-RExTM Nox4 cells were provided by Pr KH. Krause
(Geneva University, PATIM laboratory, Switzerland) [28]. Cells
were cultured in DMEM containing 4.5 g/L glucose and 0.11 g/
L sodium pyruvate, supplemented with 10% (v/v) fetal bovine
serum, 100 units/ml penicillin, 100 mg/ml streptomycin and
2 mM glutamine at 37uC in atmosphere containing 5% CO2 [27].
Blasticidin (5 mg/ml) and G418 (400 mg/ml) were used for
HEK293 T-RExTM Nox4 cells. For experiments with IL-1b,
complete cell culture medium was replaced by serum free DMEM.
C-20/A4 chondrocytes were then stimulated with IL-1b supple-
mented or not with antioxidants during 48h for MMP-1 assay and
5 days for cell death assessment. All experiments were performed
within cell passages 3 to 10 at 60–90% confluence.
Generation of Plasmid Constructs for Heme Oxygenase-1
(HO-1) Expression
Human HO-1 cDNA was obtained by PCR after RNA
extraction and cDNA amplification from CoPP-IX treated C-
20/A4 chondrocytes. HO-1 sequence amplification was realized
with the forward primer HO-1-F1 (59 GTTTAAGCTTATG-
GAGCGTCCGCAACCCGAC 39) including a Hind III site (in
bold type) and the reverse primer HO-1-R1 (59
CTTTCTCGAGTCACATGGCATAAAGCCCTACAGC 39)
comprising a Xho I restriction site (in bold type). The purified
HO-1 PCR product was subcloned into the pcR Blunt II-TOPO
vector according to the manufacturing protocol (Zero Blunt
TOPO PCR cloning kit, (Invitrogen)). pcR-Blunt II-TOPO
plasmid containing HO-1 encoding sequence was digested by
Hind III and Xho I, and HO-1 insert was ligated into linearized
pcDNA 3.1 vector (Invitrogen). Plasmid encoding for HO-1 was
checked by sequencing (Genome Express, Grenoble, France).
Stable Transfection of Mammalian Expression Plasmids
C-20/A4 chondrocyte cells were trypsinized and counted.
46105 C-20/A4 cells were seeded in 6-well plates and allowed to
grow for 24h to reach a 60% confluence in 2 mL complete
DMEM culture medium. Cells were transfected with 1 mg of pEFb
vectors encoding for Nox4A or Nox4B or 1 mg pcDNA3.1 vector
encoding for Nox4GFP or HO-1 according to the manufacturing
protocol (FuGENE, Roche). After 24 h, transfected cells were
selected for 3 weeks with 10 mg/ml blasticidin for pEFb vector or
900 mg/ml geneticine for pcDNA3.1.
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Measurement of NADPH Oxidase Activity in Intact Cells
by Luminescence Assay
ROS production was measured as described by Grange et al
[22]. Briefly, cells were detached with trypsin, washed twice with
PBS and collected by centrifugation (400 g, 8 min, RT). The
viability of the suspended cells was over 90%, as determined by the
trypan blue exclusion method. In a 96-well plate, 56105 living
cells resuspended in 50 ml were added per well. Before the start of
the assay, 200 ml of a PBS solution containing 20 mM luminol, and
10 units/ml of horseradish peroxidase was added in each well.
Relative luminescence unit (RLU) counts were recorded every 30 s
for a total of 45 min at 37uC using a LuminoscanH luminometer
(Labsystems, Helsinki, Finland).
Cell Extracts Preparation
Cells were treated with 3 mM DFP and lysed in Triton X-100
lysis buffer containing 20 mM Tris-HCl pH 7.4, 1% (v/v) Triton
X-100, 150 mM NaCl, 1 mM EDTA, 10 mM Na4P2O7, 10 nM
okadaic acid, 2 mM Na3VO4, 2 mg/ml leupeptin, 2 mg/ml
pepstatin, 10 mg/ml trypsin inhibitor, 44 mg/ml PMSF, 10 mM
TLCK and complete mini EDTA-free protease inhibitor (Triton
X-100 cell extract). After 10 min incubation on ice, the mixture
was centrifuged at 1000 g for 10 min at 4uC. The supernatant was
then used for SDS-PAGE and Western Blotting or cytochrome b
spectroscopy.
Reduced Minus Oxidized Difference Spectra of Nox4
Reduced minus oxidized difference spectra were performed on
Triton X-100 extract from C-20/A4 chondrocytes transfected or
not with Nox4 and HMOX1 genes (HMOX1 encoded for HO-1).
Reduction was achieved in the cuvette by addition of a few grains
of sodium dithionite, and reduced minus oxidized difference
spectra were recorded at room temperature with a DU 640
spectrophotometer (Beckman Coulter, Roissy, France). The
amount of cyt b was determined by absorbance at 426 nm using
the e value of the cytochrome b558 of Nox2 (106 mM
21cm21). A
positive control was performed on cytochrome b558 purified from
human neutrophils [29].
SDS/PAGE and Western Blotting
Triton X-100 cell extract or centricon 10X concentrated cell
culture supernatant were denatured at 60uC for 30 min or 4uC
overnight and loaded on 10% or 12.5% (p/v) SDS-PAGE for
migration and then electro-transfer to nitrocellulose. Immunode-
tection was performed using antibodies raised against Nox4 (mAb
8E9 or 6B11, 1:500) [27], MMP-1 (1:500), HO-1 (1:500), Actin
(1:1000) or VDAC (1:1000). Secondary antibody was conjugated
to peroxidase (1:5000). Peroxidase activity was detected using ECL
reagents (GE Healthcare).
Flow Cytometry
To assess the DNA fragmentation, C-20/A4 chondrocytes were
fixed overnight in ice cold absolute ethanol, washed twice in PBS
and 26106 cells were stained with 50 mg/ml propidium iodide in
presence of 100 mg/ml RNAse. After 30 min incubation on ice,
propidium iodide emission of fluorescence (615 nm) was assessed
by FACS. Plasma membrane localization of Nox4 was assessed on
HEK293 T-RExTM Nox4 cells induced for Nox4 expression with
tetracycline and treated or not with 25 mM Cobalt Protoporphy-
rin-IX (CoPP-IX) or 25 mg/ml succinylacetone during 48 h. 106
unpermeabilized cells were then suspended in 150 mL PBS
containing 0.2% (w/v) BSA and 0.5 mM CaCl2 (PBS/BSA/
CaCl2 buffer) and incubated on ice for 30 min with 5 mg of mouse
monoclonal Ig (irrelevant Ig or 8E9 mAb) [27]. Cells were washed
twice and resuspended in 150 ml of the Alexa Fluor 488 goat anti-
mouse antibody diluted 1:200 in PBS/BSA/CaCl2 buffer. After
30 min incubation on ice, cells were washed twice and fluores-
cence intensity was assessed. All FACS experiments were
performed on a FACSCanto II cytometer (Becton Dickinson).
Confocal Microscopy
Nox4GFP overexpressing C-20/A4 chondrocytes were seeded
on coverslips for 48 h and treated or not with 25 mM Cobalt
Protoporphyrin-IX or 25 mg/ml succinylacetone. When conflu-
ence reached 60%, cells were fixed with 4% (w/v) paraformalde-
hyde (PFA) for 10 min and PFA fluorescence was quenched by
50 mM NH4Cl for 10 min at RT. Nox4 subcellular localization in
C-20/A4 chondrocytes was assessed by 1 h incubation at room
temperature with 5 mg of mouse monoclonal Ig (irrelevant Ig or
8E9 mAb) in 200 ml of PBS containing 1% (w/v) BSA (PBS/BSA
buffer). Cells were then washed twice with PBS/BSA buffer and
permeabilized with 0.1% (v/v) Triton X-100 during 10 min at
RT. Non treated and HO-1 induced chondrocytes were stained
for 1h at RT with a goat anti HO-1 antibody (1/50 in PBS/BSA
buffer). Meanwhile, succinylacetone treated cells were incubated
at RT with 5 mg rabbit anti calnexin antibody in 200 ml PBS/BSA
buffer. After two washes with PBS/BSA buffer, 1 h incubation
with anti-goat (for HO-1 labeled cells) or anti-rabbit (for calnexin)
secondary antibodies conjugated to Alexa 546 (1/200) was
performed at RT in PBS/BSA buffer. Finally, plasma membrane
Nox4/8E9 mAb complex was revealed with 1h incubation at RT
with a goat anti-mouse antibody conjugated to Alexa 633 diluted
1/200 in PBS/BSA buffer. For Nox4/p22phox heterodimer
formation study, C-20/A4 chondrocytes were permeabilized for
10 minutes with 0.1% (v/v) Triton X-100 and were stained for 1h
with 5 mg of 16G6 mAb directed against p22phox [30] in 200 ml
PBS/BSA buffer. After two washes, p22phox staining was revealed
with a goat anti mouse antibody labeled Alexa 546 (red). In all
experiments, cell nuclei were stained with Hoechst 33258 (0.5 mg/
ml) and mounted in DABCO solution; they were sealed, and
stored at 4uC in the dark. Confocal microscopy was carried out by
using the Zeiss LSM510 NLO META. The pinhole was adjusted
to 1 Airy unit resulting in 0.7 mm thick slices. Hoechst fluores-
cence was visualized using a 2P excitation.
Statistical Data
Data are presented as means +/2 S.D., significance levels are
assessed using Student’s paired t test. A p-value of 0.05 or less
between groups is considered to indicate a statistically significant
difference.
Results
Nox4 Mediates IL-1ß-effects on MMP-1 Secretion and
DNA Fragmentation in C-20/A4 Chondrocyte Cells
Our previous studies showed that Nox4 is involved in MMP-1
expression in C-20/A4 human chondrocyte cells [22]. To assess
the role of Nox4 in chondrocytes, we generated a C-20/A4
chondrocyte cell line that provided a stable expression of Nox4A
(Genbank No.AF254621), or Nox4B (Genbank No. AY288918)
(Figure 1A). Nox4A correspond to the commonly described wild
type Nox4. Nox4B is a splice variant in which the first NADPH
binding site is missing and corresponds to a non functional
enzyme. It has been described as a dominant negative variant in
A549 cells [31]. Results showed a significant production of ROS
by luminescence in Nox4A transfected cells compared with the
cells that overexpress Nox4B (Figure 1B). Moreover, the ROS
HO-1 Regulates Nox4 Activity in Chondrocytes
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produced was neutralized by Tiron, an antioxidant molecule.
After 24 h stimulation by 2 ng/ml IL-1b, a 12 fold increase of
MMP-1 expression was observed by Western Blot in the media
supernatant of the Nox4A transfected C-20/A4 chondrocytes
(Figure 1C). Interestingly, the addition of 5 mM Tiron completely
inhibits the effect of IL-1b on MMP-1 expression, strengthening
the role of ROS on MMP-1 induced expression. Contrary to
Nox4A, Nox4B transfected chondrocytes slightly increased by
3 fold the secretion of MMP-1 upon IL-1b stimulation. These
data confirmed our previous observation that MMP-1 synthesis in
C-20/A4 chondrocytes upon IL-1b signalling is mediated by Nox4
oxidase activity [22]. As reported, IL-1b triggers chondrocyte
apoptosis [32]. We next investigate the DNA fragmentation level
and found a 80% increase of cell death (SubG1 population) of
Nox4A transfected chondrocytes by flow cytometry after 5 days
incubation with 10 ng/ml IL-1b compared to the control
chondrocytes transfected with Nox4B gene (Figure 1D). The
scavenging of ROS production by N-acetyl cystein prevented the
observed cell death (Figure S1A). Consistently, the exposure of
WT chondrocytes to either H2O2 (Figure S1B left panel) or IL-1b
(Figure S1B right panel) led to an increase of DNA fragmentation
in a dose dependent manner that is inhibited by the addition of
catalase PEG. All together, these data confirm that ROS and more
specifically H2O2 produced by Nox4A upon IL-1b stimulation
induced C-20/A4 chondrocyte cell death and MMP-1 secretion.
HO-1 Overexpression Decreases Nox4 Activity in C-20/A4
Chondrocytes
Heme molecules (heme A and B) are essential to NADPH
oxidase activity [33]. Therefore, decreasing of heme availability by
modulating of HO-1 expression may affect Nox4 activity. We
found that HO-1 expression was dose-dependently induced in C-
20/A4 chondrocytes (Figure S2A) and HEK293 T-RExTM (Figure
S2C) cells after 48 h incubation with 10 or 25 mM cobalt
protoporphyrin-IX (CoPP-IX). Interestingly, incubation with
CoPP-IX consequently decreased the ROS production in Nox4A
chondrocytes (Figure 2A). Similar reduction (by 50%) of ROS
production was obtained when HO-1 protein was overexpressed
in Nox4A C-20/A4 chondrocytes (Figure 2B and S2B). To
confirm that the observed effect of HO-1 was specifically related to
Nox4 protein, we used another cellular model, HEK293 T-
RExTM Nox4 cells, in which the expression of Nox4 is induced by
the addition of tetracycline [28]. HO-1 expression was chemically
induced by CoPP-IX in HEK293 T-RExTM Nox4 cells (Figure
S2C) and the results confirmed a CoPP-IX dependent decrease of
Nox4 activity up to 80% after 72 h HO-1 induction (Figure S3A).
We confirmed those results by using the Amplex Red assay,
another ROS detection method (Figure S3B). These data indicate
that HO-1 act as a negative regulator of Nox4 activity in those two
different cellular models.
HO-1 Decreases MMP-1 Expression and Chondrocytes
DNA Fragmentation
We have shown that ROS generated by Nox4 are directly
involved in the expression of MMP-1 and cell death in the C-20/
A4 chondrocyte cells. We next investigated whether the increase of
HO-1 expression could affect MMP-1 secretion induced by IL-1b.
HO-1 expression was induced by 48 h incubation with CoPP-IX
or by stable HO-1 gene transfection in Nox4A transfected
chondrocytes. The amount of MMP-1 secreted in the media
supernatant was evaluated by Western Blot after 48h stimulation
by IL-1b. The overexpression of HO-1 by transfection reduced 4
times the quantity of MMP-1 in the media supernatant of Nox4A
chondrocytes compared to control EV transfected cells (Figure 3A).
Consistently, the HO-1 induction by CoPP-IX totally abolished
the MMP-1 secretion and DNA fragmentation mediated by
Nox4A upon IL-1b treatment. Interestingly, similar but milder
significant effects were also observed on WT cells, probably due to
the presence of the endogenous Nox4 protein (Figure S4). By
contrast, no significant effects of HO-1 were noticeable on MMP-
1 secreted by cells expressing Nox4B suggesting a potential
dominant negative effect of this splice variant (Figure 3B).
Together, these data confirm that the regulation of Nox4 activity
Figure 1. Nox4 mediates IL-1ß-effects on MMP-1 secretion and
DNA fragmentation in C-20/A4 chondrocyte cells. (A) Predicted
linear domain structure of Nox4A, the functional isoform and Nox4B,
deleted for a putative NADPH binding site. (B) ROS production was
measured by chemiluminescence on 56105 intact C-20/A4 chondro-
cytes overexpressing Nox4A or Nox4B treated or not with 5 mM of
Tiron. Results are expressed as the sum of all RLU measurements
recorded every 30 s during 45 min. Values represent the mean +/2 S.D.
of four determinations obtained the same day. * p,0.05 versus
untreated Nox4A cells. (C) C-20/A4 chondrocytes transfected with
genes encoding for Nox4A or Nox4B were stimulated or not with 2 ng/
ml IL-1ß with or without 5 mM Tiron. After 48h, supernatant was
collected, concentrated 10 times by centricon and 10 mg of proteins
were loaded for MMP-1 immunodetection by Western Blot. Results are
representative of three independent experiments. (D) C-20/A4 chon-
drocytes transfected with genes encoding for Nox4A or Nox4B were
treated or not with 10 ng/ml IL-1ß. After 5 days, cells were detached
and fixed with ice cold absolute ethanol. Cells were then washed twice
in PBS and stained with propidium iodide before flow cytometry
acquisition. * p,0.05 versus Nox4B cells.
doi:10.1371/journal.pone.0066478.g001
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by HO-1 influences directly MMP-1 secretion as well as
chondrocytes death.
Heme Availability does not Modify Nox4 Total Protein
Expression but Affects Nox4 Subcellular
Compartmentation
Heme molecules are necessary for Nox2 dimerization with its
stabilizing subunit p22phox and maturation, and for plasma
membrane addressing of the mature heterodimer (cytochrome
b558) in PLB-985 cells [25]. In the absence of hemes, Nox2 is
unstable and is degraded by the proteasome [26]. Thus, we
evaluated the molecular impact of heme catabolism by HO-1 on
Nox4 expression. We did not observed significant changes in Nox4
expression when HO-1 was overexpressed either by transfection or
by CoPP-IX induction in both C-20/A4 and HEK293 T-RExTM
Nox4 cell types compared to untreated cells (Figure 4A, 4B and
4F). These results therefore demonstrate that HO-1 decreases
Nox4 activity without affecting significantly its expression. Given
the extremely short half-life of superoxide that dismutes quickly
into H2O2, the site of its production determines its biological
impact. The effect of HO-1 on Nox4 subcellular localization was
assessed in the C-20/A4 chondrocytes. Consistent with data
shown in HEK293 cells [27], transfection of Nox4GFP fusion gene
led to endoplasmic reticulum (ER) and plasma membrane
localization of the fusion protein in C-20/A4 chondrocytes by
confocal microscopy (Figure 4C). Plasma membrane localization
of Nox4GFP was confirmed by using 8E9 antibody that recognizes
an extracellular epitope of Nox4 protein [27] and that was added
before cell permeabilization (Figure 4C, right panel). After 48h
incubation with 25 mM CoPP-IX, a clear induced expression of
HO-1 was evidenced in C-20/A4 chondrocytes that was co-
localized with Nox4GFP fusion protein (Figure 4C). We observed
that upon 25 mM CoPP-IX incubation, Nox4 remained expressed
at the plasma membrane as illustrated by the 8E9 mAb staining
(Figure 4C, right panel). Interestingly, after treatment with the
heme synthesis inhibitor succinylacetone (SA), the total amount of
Nox4 protein was not affected (Figure 4B) whereas its plasma
membrane localization seemed compromised since a large
majority of Nox4GFP proteins remained in the ER and were
co-localized with calnexin, an endoplasmic reticulum marker
(Figure 4D).
To confirm those observations, we used another cellular model
HEK 293 T-RExTM (Figure 4E and 4F). Nox4 subcellular
localization was assessed by flow cytometry using the 8E9 mAb
on unpermeabilized tetracycline induced T-RExTM Nox4A cells.
We observed that Nox4 expression at the plasma membrane after
48h tetracycline induction was not affected by the increase of HO-
1 expression upon 48h CoPP-IX treatment (Figure 4E). On the
contrary, 24h treatment with SA decreased by 60% the plasma
membrane expression of Nox4 (Figure 4E) without affecting the
total amount of Nox4 protein (Figure 4F). These data together
suggest that the inhibition of heme synthesis by SA treatment
rather than the catabolism of heme mediated by HO-1 affects
plasma membrane localization of Nox4GFP which remains
confined in the synthesis compartment (ER).
Inhibition of Heme Synthesis, Rather than Heme
Catabolism by HO-1, Alters Nox4/p22phox Dimer
Formation and Heme Integration
Since cellular heme content influences Nox4 compartmentation
and potentially its maturation, the consequence of a modulation of
heme amount on Nox4/p22phox heterodimer formation was
investigated (Figure 5). In absence of HO-1, confocal images
showed a strict co-localization of Nox4GFP fusion protein with
p22phox in C-20/A4 chondrocytes arguing in favour of the
presence of a mature Nox4/p22phox complex (Figure 5A).
Interestingly, SA treatment abolished this co-localization whereas
the induction of HO-1 by CoPP-IX did not (Figure 5A). We next
assessed the spectral properties of Nox4/p22phox. The Nox2/
p22phox heterodimer, named cytochrome b558 is characterized by a
redox spectrum with three absorption bands at 426, 530 and
558 nm. Due to a high homology between Nox4 and Nox2, the
Nox4/p22phox heterodimer may display similar spectral properties
[22]. 1% (v/v) Triton X-100 protein extracts from WT, Nox4A or
Nox4A HO-1 transfected C-20/A4 chondrocytes were prepared.
Reduced minus oxidized difference spectra were measured
(Figure 5B). Similar to cyt b558, results showed a slight peak at
426 nm (the Soret Band) in WT chondrocytes that was
significantly enhanced (3.5 fold) in chondrocytes overexpressing
Nox4A. To verify that this increase in absorbance at 426 nm was
specific to Nox4 overexpression and not from a mitochondria
contamination, we evaluated the expression level of VDAC, a
mitochondria marker. We found that VDAC level was even in all
samples, resulting in an increase of Abs426nm/VDAC ratio in
Figure 2. HO-1 overexpression decreases Nox4 activity in C-20/
A4 chondrocytes. (A) C-20/A4 chondrocytes were treated or not with
10 or 25 mM CoPP-IX for 48 h. Nox4 activity was then measured by
chemiluminescence from 56105 WT or Nox4A transfected cells. RLU
were recorded every 30 s for 45 min as described in material and
methods. * p,0.05 versus untreated Nox4 cells. (B) Similar experiments
were also performed on chondrocytes (WT and Nox4A) stably
transfected with HO-1 or the empty vector (EV) as described in material
and methods. Values represent the mean +/2 S.D. of three
determinations obtained the same day and are representative of three
independent experiments. * p,0.05 versus EV Nox4 cells.
doi:10.1371/journal.pone.0066478.g002
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protein extract from Nox4A chondrocytes compared with protein
extracts from WT (Figure S5). In the absence of a known molar
extinction coefficient at 426 nm (e426) value for Nox4, we
estimated the amount of Nox4/p22phox dimer (cyt b) of Nox4
using the e426 value of the cytochrome b558. 22 pmol of cyt b per
mg protein extract was initially found in WT cells and was
increased up to ,70 pmol cyt b per mg of proteins in Nox4
transfected cells (Figure 5B and 5C). In addition, overexpression of
HO-1 slightly decreased the cyt b amount (from 70 to 50 pmol/mg
of protein). Conversely, no spectra were observed upon SA
treatment (Figure 5B and 5C) which is correlated to an absence of
ROS production under those conditions (unpublished data).
Taken together, these data show that the presence of heme
molecules is necessary for the Nox4/p22phox heterodimerization.
However, despite a significant inhibitory effect of HO-1 on Nox4
activity, the maturation of the Nox4/p22phox heterodimer appears
not significantly affected by HO-1.
Carbon Monoxide Decreases Nox4 Activity and MMP-1
Expression
A possible mechanism of action of HO-1 on Nox4 activity could
be mediated by heme degradation by-products (Carbon monoxide
(CO), Biliverdin (BV) and Bilirubin (BR)). The consequences of
CO have been studied on Nox1 and Nox2 activity [34,35,36] but
not on that of Nox4 so far. In order to investigate whether CO
Figure 3. HO-1 decreases MMP-1 expression and chondrocytes DNA fragmentation. (A and B) C-20/A4 chondrocytes overexpressing
Nox4A or Nox4B were induced or not for HO-1 expression with 10 or 25 mM CoPP-IX for 48h (A). C-20/A4 Nox4A chondrocytes were stably
transfected with HMOX1 gene (encoding for HO-1) or the empty vector (EV) (B). Cells were stimulated or not with 2 ng/ml IL-1ß. After 48h, the media
supernatant was collected, concentrated 10 times by centricon. 10 mg of proteins were loaded on 10% SDS-PAGE for MMP-1 immunodetection by
Western Blot. (C) C-20/A4 Nox4A chondrocytes were treated or not with 10 ng/ml IL-1ß +/210 mM CoPP-IX for 5 days in DMEM 2% fetal bovine
serum. Cells were then washed, fixed with ice cold ethanol, stained with propidium iodide and 56105 cells fluorescence was assessed by FACS.
Results are representative of three independent experiments.
doi:10.1371/journal.pone.0066478.g003
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interfere with Nox4 activity, we evaluated the effects of CORM-II,
a CO donor [37], on tetracycline induced HEK293 T-RExTM
Nox4 cells. CORM-II decreased significantly (by 75%) the
production of ROS whereas the control RuCl compound which
do not release CO had no effect (Figure 6A). To avoid a potential
antioxidant property mediated by CORM-II itself independently
of the presence of CO, CORM-II was prepared extemporaneously
or 24 h before (time necessary to CO to totally volatized) its
supplementation to the cells. Indeed, a significant decrease of
Nox4 activity was only observed with 50 mM CORM prepared
extemporaneously and not with those prepared 24 h earlier
(Figure S6). The inhibitory effect of CO was confirmed on Nox4A
transfected C-20/A4 chondrocytes in which CORM-II decreased
significantly the ROS production by 50% (Figure 6B).
Finally, we tested whether the inhibition of Nox4 activity by CO
could prevent the MMP-1 secretion induced by IL-1b. For this we
treated IL-1b-induced Nox4A transfected C-20/A4 cells with
100 mM of CORM-II or RuCl (control) and evaluated the amount
of MMP-1 secreted. CORM-II reduced by approximately half the
quantity of MMP-1 secreted in the media supernatant compared
to the control RuCl (Figure 6C) strengthening the link in the IL-1b
induced pathway between HO-1, CO, Nox4 activity, MMP-1
secretion and DNA fragmentation.
Discussion
Physiological relevance of ROS in chondrocyte physiology
remains elusive. ROS might play an important role in chondro-
genesis [13,14]. Indeed, previous works have reported a role for
ROS in mediating chondrocyte hypertrophy during endochondral
ossification. However, hypertrophic phenotype is also observed
among osteoarthritic chondrocytes which die by apoptosis [12]
and NADPH oxidase Nox4 may contribute to this phenomenon
[13]. Furthermore, pseudoachondroplasia, a genetic pathology
caused by a mutation on the protein COMP (Cartilage Oligo
Matrix Protein) is characterised by abnormal joint architecture,
joint erosion and osteoarthritis. Interestingly, a recent study
showed a 100 fold increase of Nox4 mRNA in Rat Chondrosar-
coma Cells (RCS) expressing mutated COMP [21]. Necroptosis, a
caspase independent cell death process was triggered in chondro-
cytes following DNA damages induced by ROS. Therefore, while
the implication of ROS in chondrocyte pathologies has been
suggested, no studies on the specific role of NADPH oxidase Nox4
was proposed until yet.
The extracellular matrix catabolism and chondrocyte death are
the two main causes leading to cartilage degradation and
osteoarthritis. In this study, we demonstrated for the first time
the involvement of Nox4 derived ROS in DNA fragmentation and
chondrocyte death under IL-1b cytokinic stress. Moreover, we
identify a mechanism of regulation of Nox4 activity by HO-1
through CO generation as by-product of heme degradation
validated in two different cellular models. Our findings indicate
that the use of the CO generation compound (CORM-II) or the
induced expression of HO-1 down-regulates the ROS production
by Nox4 in human C-20/A4 chondrocytes that consequently
reduce MMP-1 secretion and cell death, two main features in
osteoarthritis. Those observations raise the prospect that targeting
Nox4 activity and HO-1 may represent novel therapeutic
strategies in OA.
It is well known that Nox2 expression, heterodimerization with
p22phox and addressing to the plasma membrane are dependent
on the presence of heme molecules [25]. In this work we studied
the impact of heme metabolism on Nox4 expression, subcellular
compartmentation and maturation by comparing the effect of
HO-1 that catalyzes the degradation of heme to that of
succinylacetone, a heme synthesis inhibitor. The localization at
the plasma membrane is a good indication of the mature state for
Nox2. Consistently with our previous observation in HEK293 T-
RExTM cells [27], we found that functional Nox4 is partly
expressed at the plasma membrane in C-20/A4 chondrocytes.
Our data, showing that the inhibition of heme synthesis rather
than heme degradation induces its retention in the endoplasmic
reticulum and absence to the plasma membrane, indicate that
heme incorporation by Nox4 is a prerequisite to its dimerisation
and maturation. Indeed, a SA treatment eradicates totally the
Nox4 redox differential spectrum measured indicating the absence
of prosthetic heme group. A role of heme in Nox4/p22phox
heterodimerization was suggested by Ambasta and coworkers by
substituting the histidine 115 with a Leucine [38]. This mutation
located on a putative heme coordination site disrupted the Nox4/
p22phox heterodimer. Conversely, the induced expression of HO-1
is unable to remove significantly hemes incorporated in Nox4/
p22phox complex characterized by an intact differential spectrum.
Here, we demonstrate that in absence of heme, Nox4/p22phox
maturation, plasma membrane addressing and NADPH oxidase
activity are abolished without affecting the total expression of
Nox4. This contrasts with the observation made by Taille´ and co-
workers showing that HO-1 decreases the heme bioavailability
and consequently Nox2/p22phox expression in RAW264.7 mac-
rophages [39]. Our data are consistent with previous findings in
rat aortic tissue [40], where the production of ROS was decreased
without any change in both Nox2 and Nox4 expression after HO-
1 induction by hemin. However, this in vivo study could not
discriminate whether the source of ROS production is Nox2 or
Nox4.
In this work we demonstrate that HO-1 is able to modulate
Nox4 activity and validate that effect in two different cellular
models. Indeed, upon induction of HO-1 expression with CoPP-
IX or plasmid overexpression, a significant decrease of Nox4
oxidase activity was observed in the HEK293 T-RExTM cells and
Figure 4. Heme availability does not modify Nox4 total protein expression but affects Nox4 subcellular compartmentation. (A and
B) C-20/A4 Nox4A chondrocytes were transfected with HO-1 encoding vector or the empty vector (EV) ((1) and (2) are from two independent stable
transfections) (A) or were treated with 25 mM CoPP-IX or 25 mg/ml SA during 48h (B). Nox4 expression was then assessed by Western Blot with 8E9
antibody on 150 mg of protein from 1% (v/v) Triton X-100 extract. VDAC protein served as loading control. (C and D) Nox4GFP overexpressing C-20/
A4 chondrocytes were treated or not with 25 mM CoPP-IX (C) or 25 mg/ml succinylacetone (D) for 48h. (C) Cells were fixed with 4% paraformaldehyde
(PFA) and plasma membrane Nox4 was stained with 8E9 mAb before cell permeabilization. Cells were then permeabilized with 0.1% (v/v) Triton X-
100 and immunostained for HO-1 (red). Right panels show the 8E9 mAb immunostaining (white arrows) with the nucleus. (D) SA treated Nox4GFP
expressing chondrocytes were fixed with 4% PFA and permeabilized with 0.1% (v/v) Triton X-100. Cells were then immunolabelled with calnexin (red)
and nucleus was stained with Hoechst 33258 (blue). (E and F) HEK293 T-RExTM cells were induced or not for Nox4 expression with tetracycline (Tet)
and for HO-1 with 25 mM CoPP-IX or were treated with 25 mg/ml SA during 48 h. (E) Nox4 expressed at the plasma membrane was stained with 8E9
mAb (recognizing an extracellular epitope of Nox4). Plasma membrane Nox4 expression was then quantified by flow cytometry. Non-induced (NI)
cells are displayed in grey solid line, tet-induced cells in black continuous line, tet-induced cells treated by CoPP-IX in black dotted line and tet-
induced cells treated with SA in grey continuous line. (F) Total Nox4 expression was assessed by Western Blot with 8E9 antibody on 150 mg of protein
from a 1% (v/v) Triton X-100 extract. Actin protein served as loading control. Results are representative of three independent experiments.
doi:10.1371/journal.pone.0066478.g004
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Figure 5. Inhibition of heme synthesis, rather than heme catabolism, affects Nox4/p22 dimer formation and heme integration. (A)
Nox4GFP C-20/A4 chondrocytes were treated with 25 mM CoPP-IX or 25 mg/ml SA during 48 h. Cells were then fixed with PFA, permeabilized and
p22phox was stained with 16G7 mAb antibody (red). The nucleus was stained with Hoechst 33256 (blue). (B) WT and Nox4 chondrocytes were treated
or not with succinylacetone (25 mg/ml during 48 h) or were transfected with HO-1. Reduced minus oxidized difference spectra of Nox4 were assessed
on 5 mg/ml of proteins from a 1% (v/v) Triton X-100 extracts. The positive control was obtained with cytochrome b558 purified from human
neutrophils. (C) Concentration of cytochrome b in the extract was calculated with a e426 nm value of 106 mM
21 cm21.
doi:10.1371/journal.pone.0066478.g005
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C-20/A4 chondrocytes. Similar data were previously reported in
which the Heme oxygenase isoform HO-2 was shown to decrease
Nox4 activity in microvasculature [41]. To our knowledge, it is the
first time that HO-1 is reported as a regulator of Nox4 activity. We
studied the HO-1 capability to inhibit Nox4 activity in the IL-1b
pathway leading to events that participate to the progression of
OA. We showed that inducing or overexpressing HO-1 proteins
strongly reduces the matrix metalloproteinase MMP-1 secretion
and chondrocyte cell death, therefore acting potentially to prevent
cartilage degradation.
Unlike the SA treatment that abolishes Nox4 activity by
affecting its heterodimerization and maturation, it is intriguing to
observe that the induced expression of HO-1 inhibits Nox4
activity without affecting Nox4 synthesis pathway. This raises the
hypothesis that HO-1 could interfere directly or indirectly with
Nox4 activity itself. The cellular concentration of heme is
depending on the equilibrium between expression of hemopro-
teins, heme synthesis and heme degradation catalyzed by Heme
oxygenase-1 to gives rise to carbon monoxide, biliverdin and
bilirubin (CO, BV and BR) [24]. Among them, CO was shown to
modulate Nox1 and Nox2 activity [34,35,36]. Moreover, CO may
decrease both ROS and NO production in osteoarthritic
chondrocytes stimulated by IL-1b [37]. This was associated to a
weak expression of MMP-1, MMP-3, MMP-10 and MMP-13
[42]. In our study, we showed that CO reduces Nox4 activity. At
least other 3 studies suggested a direct binding of CO on Nox1 and
Nox2 [34,35,36]. However, it was demonstrated the absence of
binding of CO on cytochrome b558 [43]. Our data actually could
not discriminate whether the impact of CO on Nox4 is direct or
not; nevertheless, the CO donor CORM-II decreased significantly
MMP-1 secretion and ROS production by IL-1b stimulated C-
20/A4 chondrocytes.
Taken together, our results suggest that Nox4 is directly
involved in MMP-1 expression and C-20/A4 chondrocyte death
under IL-1b cytokinic stress. HO-1 is a negative modulator of
Nox4 oxidase activity but does not significantly impact on its
expression, subcellular localization and dimerization with its
partner p22phox. On the other hand, inhibition of heme synthesis
by succinylacetone affects profoundly maturation and function of
Nox4. Therefore, inhibition of Nox4 activity by HO-1 is not due
to the consequence of a decrease of heme bioavailability for Nox4,
but mainly to CO production and its effect on oxidase activity.
These in vitro results highlight a possible role for Nox4 in OA,
mediating pro-catabolic effect of IL-1b. Whether Nox4 is a
physiological target or not in OA is currently under investigation
in human primary chondrocytes. Nevertheless, homeostasis of the
cartilage may depend on the balance between the expression of
Nox4 and HO-1 and targeting those protein’s functions may
provide therapeutic benefits for the treatment of articular
conditions.
Supporting Information
Figure S1 Nox4 derived ROS mediate IL-1b induced cell
death. (A) Pictures taken under inverted microscope of C-20/A4
chondrocytes transfected with Nox4A or Nox4B encoding genes.
Cells were treated with 10 ng/ml IL-1b, +/2500 nM N-acetyl
cystein (NAC) during 5 days. Representative picture illustrating
cell death by floating cell and low confluency compared to the
untreated cells. (B) C-20/A4 WT chondrocytes were treated with
increasing concentration of H2O2 (0; 100; 250 or 500 mM) or with
IL-1ß (0; 2 or 10 ng/ml) +/2 catalase-PEG 200 U. After 5 days,
cells were detached and fixed with ice cold absolute ethanol. Cells
were then washed twice in PBS and stained with propidium iodide
before FACS acquisition.
(TIF)
Figure S2 HO-1 is induced by CoPP-IX or plasmid
transfection. (A) C-20/A4 chondrocytes were treated 48 h with
10 or 25 mM CoPP-IX or (B) were stably transfected with HO-1
encoding plasmid. (C) HEK 293 T-RExTM Nox4 cells were
treated 48 h with 10 or 25 mM CoPP-IX. (A, B and C) Cells were
Figure 6. Carbon monoxide (CO) decreases Nox4 activity and
MMP-1 expression. (A) Tet induced HEK293 T-RExTM Nox4 cells were
treated for 1h with 100 mM CORM (a CO donor) or RuCl (the control
molecule). Histogram shows the RLU sum obtained from the 45 min
kinetic of Nox4 activity from 56105 cells assessed by chemilumines-
cence. * p,0.05 versus RuCl treated cells. (B) 56105 C-20/A4
chondrocytes were pre-treated for 1 h with 100 mM CORM or RuCl.
Nox4 activity was then assessed by chemiluminescence. Results are
expressed as percentage of RuCl treated cells. Values represent the
mean +/2 S.D. of determinations in triplicate obtained the same day. *
p,0.05 versus RuCl treated cells. (C) C-20/A4 Nox4A chondrocytes were
stimulated with 2 ng/ml IL-1b and treated with 100 mM CORM or the
control RuCl for 16 h. Medium supernatant was then collected and
concentrated 10 times by centricon. 10 mg of proteins were loaded on
10% SDS-PAGE for MMP-1 immunodetection by Western Blot. Results
are representative of three independent experiments.
doi:10.1371/journal.pone.0066478.g006
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then lysed by using a Triton X-100 extract. HO-1 expression was
assessed by Western Blot. (D) Confocal microscopy shows HO-1
immunostaining (red) of C-20/A4 chondrocytes induced or not for
HO-1 expression with 25 mM CoPP-IX during 48 h. Results are
representative of three independent experiments.
(TIF)
Figure S3 HO-1 decreases Nox4 activity in HEK293 T-
RExTM Nox4 cells. (A) Cells were treated or not with CoPP-IX
in order to induce HO-1 expression. Incubation time (48 or 72 h)
and dose effect (10 or 25 mM) of CoPP-IX were assessed on ROS
production by 56105 intact tet-induced cells. Results expressed the
sum of all RLU measurements, acquired every 30s during 45 min.
(B) Tet-induced HEK293 T-RExTM cells were incubated for 48 h
with 10 or 25 mM CoPP-IX and total H2O2 production was
assessed by the Amplex Red method on 56105 cells. Results
expressed the sum of all RFU measurements, acquired every
2 min for 30 min. Values represent the mean +/2 S.D. of four
determinations obtained the same day and are representative of
three independent experiments.
(TIF)
Figure S4 Effects of HO-1 overexpression on MMP-1
secretion and cell death in WT C-20/A4. (A) WT
chondrocytes were induced for HO-1 expression with 10 or
25 mM CoPP-IX for 48h and stimulated or not with 2 ng/ml IL-
1ß. After 48h, the media supernatant was collected, concentrated
10 times by centricon. 10 mg of proteins were loaded on 10%
SDS-PAGE for MMP-1 immunodetection by Western Blot. (B
and C) C-20/A4 WT cells were treated or not with 10 ng/ml IL-
1ß +/210 mM CoPP-IX for 5 days in DMEM 2% fetal bovine
serum. (B) Cells were then washed, fixed with ice cold ethanol,
stained with propidium iodide and 56105 cells fluorescence was
assessed by FACS. (C) Culture supernatant was collected to assess
cellular membrane integrity by measuring the cytosolic LDH
activity. Results are representative of three independent experi-
ments. * p,0.05 versus IL-1b treated cells.
(TIF)
Figure S5 HO-1 does not change Nox4 expression and
heme integration. The graph shows the ratio between the
absorbance at 426nm of the differential redox spectra and
densitometric value of VDAC expression obtained by Western
Blot on the same soluble extracts used in the Figure 5B. Results
were generated from three independent experiments.
(TIF)
Figure S6 CORM does not exhibit an antioxidant
property. The effect of 50 mM CORM extemporaneously
prepared (t0h) versus prepared 24h before the experiment (t24h)
in which all the CO is volatilized, was investigated on Tet-induced
HEK293 T-RExTM cells. Nox4 activity was measured by
chemiluminescence. * p,0.05 versus CORM t24h treated cells.
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